Renhe Pharmacy Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Renhe Pharmacy Co., Ltd. carries a market capitalization of 7.52B, placing it among publicly traded companies globally. Its enterprise value stands at 4.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.52B |
| Enterprise Value | 4.70B |
Share Statistics
Renhe Pharmacy Co., Ltd. currently has 1.40B shares outstanding.
| Shares Outstanding | 1.40B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Renhe Pharmacy Co., Ltd. trades at a trailing price-to-earnings ratio of 28.63. The price-to-sales ratio is 2.85, and the price-to-book ratio stands at 1.54.
| PE Ratio | 28.63 |
| PS Ratio | 2.85 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 169.81 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Renhe Pharmacy Co., Ltd. trades at an EV/EBITDA multiple of 8.13 and an EV/FCF ratio of 99.28. The EV/Sales ratio of 1.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.13 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.67 |
| EV / EBITDA | 8.13 |
| EV / EBIT | 8.13 |
| EV / FCF | 99.28 |
Financial Position
Renhe Pharmacy Co., Ltd. maintains a current ratio of 6.58, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.03, indicating conservative leverage, while an interest coverage ratio of 9,131.22 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 6.58 |
| Quick Ratio | 5.08 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 9,131.22 |
Financial Efficiency
Renhe Pharmacy Co., Ltd. posts a return on equity of 5.43 and a return on invested capital of 5.66.
| Return on Equity (ROE) | 5.43 |
| Return on Assets (ROA) | 3.60 |
| Return on Invested Capital (ROIC) | 5.66 |
| Return on Capital Employed (ROCE) | 3.53 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.52 |
Taxes
Over the trailing twelve months, Renhe Pharmacy Co., Ltd. has paid 149.24M in income taxes, reflecting an effective tax rate of 29.58.
| Income Tax | 149.24M |
| Effective Tax Rate | 29.58 |
Stock Price Statistics
Renhe Pharmacy Co., Ltd.'s stock has declined approximately -1.63636% over the past 52 weeks. The 50-day moving average sits at 5.40, while the 200-day moving average is 5.83.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.63636% |
| 50-Day Moving Average | 5.40 |
| 200-Day Moving Average | 5.83 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Renhe Pharmacy Co., Ltd. generated 2.82B in revenue and converted that into 280.57M in net income, yielding earnings per share of 0.25. EBITDA reached 577.96M, while operating income came in at 577.96M.
| Revenue | 2.82B |
| Gross Profit | 1.05B |
| Operating Income | 577.96M |
| Pretax Income | 504.52M |
| Net Income | 280.57M |
| EBITDA | 577.96M |
| EBIT | 577.96M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
Renhe Pharmacy Co., Ltd. holds 3.99B in cash and equivalents against 2.24M in total debt, resulting in a net debt position of -1.01B. Total book value stands at 5.22B, with working capital of 4.37B providing operational flexibility.
| Cash & Cash Equivalents | 3.99B |
| Total Debt | 2.24M |
| Net Debt | -1.01B |
| Equity (Book Value) | 5.22B |
| Book Value Per Share | 3.73 |
| Working Capital | 4.37B |
Cash Flow
After subtracting -47.31M in capital expenditures, free cash flow totaled -47.31M - equivalent to -0.03 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -47.31M |
| Free Cash Flow | -47.31M |
| FCF Per Share | -0.03 |
Margins
Renhe Pharmacy Co., Ltd. operates with a gross margin of 37.18, reflecting its pricing power and cost economics. The operating margin of 20.48 and net profit margin of 9.94 provide insight into operational efficiency.
| Gross Margin | 37.18 |
| Operating Margin | 20.48 |
| Pretax Margin | 17.88 |
| Profit Margin | 9.94 |
| EBITDA Margin | 20.48 |
Dividends & Yields
The company's payout ratio of 0.11 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 0.11 |
| Shareholder Yield | 3.43 |
| FCF Yield | 0.59 |
Stock Splits
Renhe Pharmacy Co., Ltd.'s most recent stock split took place on May 26, 2015 with a 4:5 split ratio.
| Last Split Date | 5/26/2015 |
| Split Ratio | 4:5 |
Scores
Renhe Pharmacy Co., Ltd. posts an Altman Z-Score of 7.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.97 |